Human β-defensin-3gene expression in mucosa of ORL organs

The aim of present study was to investigate the hBD-3 gene expression in the surface epithelium of mucosa in ORL organs. We have studied a total of 210 mucosal samples, obtained at the most frequent surgical intervantions from 5 different anatomical functional areas: nose and paranasal sinuses, midd...

Full description

Bibliographic Details
Main Authors: E. V. Tyrnova, G. M. Aleshina, Yu. K. Yanov
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2384
_version_ 1797197799139311616
author E. V. Tyrnova
G. M. Aleshina
Yu. K. Yanov
author_facet E. V. Tyrnova
G. M. Aleshina
Yu. K. Yanov
author_sort E. V. Tyrnova
collection DOAJ
description The aim of present study was to investigate the hBD-3 gene expression in the surface epithelium of mucosa in ORL organs. We have studied a total of 210 mucosal samples, obtained at the most frequent surgical intervantions from 5 different anatomical functional areas: nose and paranasal sinuses, middle ear, nasopharynx, oropharynx, larynx. The inferior turbinate mucosa (1) and the normal middle nasal passage mucosa (2) served as controls. Estimation of hBD-3 and β-actin gene expression was performed by reverse transcription and realtime PCR. In the nasal and sino-nasal mucosa, only negligible expression levels were detected in 14.29-33.33% of samples, most often in the specimens from the middle nasal passage and ethmoid labyrinth polyps (53.84%), being absent in hypertrophic inferior turbinate. In the middle ear cavity, the frequency detection of the hBD-3 gene expression varied from 7.69% in the stapes superstructures mucosa to 53.85% of the mucosal samples in the presence of cholesteatoma. hBD-3 gene expression was detected in most tissue samples with high microbial contamination: palatine tonsils (100%); adenoid hypertrophy (84.62%); adenoids in hypertrophic states of adenoids and palatine tonsils (87.5%); laryngeal fibrous-vascular polyps (87.5%); other laryngeal pathology (77.78% of the samples). The highest levels of hBD-3 gene expression were found in laryngeal fibrous-vascular polyps. The findings presumed two functionally different types of immune response in mucosa of the ORL organs. In the anatomical-functional areas lined with ciliated epithelium (middle and inferior nasal passages, maxillary and ethmoid sinuses, middle ear), significantly lower frequencies (Fisher's exact test, p < 0.05 to p < 0.001) and levels (Mann-Whitney test, p < 0.05 to p < 0.001) of hBD-3 gene expression were detected, except of polyps of the middle nasal passage and ethmoid labyrinth, and mucosa of the tympanic cavity in cholesteatoma, which may be related to the nature of the pathological process. In the areas lined with squamous epithelium or a combination of squamous and ciliated epithelium, hBD-3 gene expression was detected almost everywhere and at significantly higher levels. In the context of chronic inflammation and infection-related diseases of the ORL organs, in addition to the direct microbicidal activity of hBD-3 as the first line of immune response, one may suggest peptide dysregulation and, even, pathogenetic effects of hBD-3, e.g., increased sensitivity to infections, pathological changes in the composition of the commensal bacteria, fibrous remodeling.
first_indexed 2024-03-08T05:47:26Z
format Article
id doaj.art-3d75264f577848a691bf39a18a550883
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:49:42Z
publishDate 2022-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-3d75264f577848a691bf39a18a5508832024-04-22T13:07:48ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2022-07-0124477979210.15789/1563-0625-HBD-23841569Human β-defensin-3gene expression in mucosa of ORL organsE. V. Tyrnova0G. M. Aleshina1Yu. K. Yanov2St. Petersburg Research Institute of Ear, Nose, Throat and SpeechInstitute of Experimental MedicineSt. Petersburg Research Institute of Ear, Nose, Throat and SpeechThe aim of present study was to investigate the hBD-3 gene expression in the surface epithelium of mucosa in ORL organs. We have studied a total of 210 mucosal samples, obtained at the most frequent surgical intervantions from 5 different anatomical functional areas: nose and paranasal sinuses, middle ear, nasopharynx, oropharynx, larynx. The inferior turbinate mucosa (1) and the normal middle nasal passage mucosa (2) served as controls. Estimation of hBD-3 and β-actin gene expression was performed by reverse transcription and realtime PCR. In the nasal and sino-nasal mucosa, only negligible expression levels were detected in 14.29-33.33% of samples, most often in the specimens from the middle nasal passage and ethmoid labyrinth polyps (53.84%), being absent in hypertrophic inferior turbinate. In the middle ear cavity, the frequency detection of the hBD-3 gene expression varied from 7.69% in the stapes superstructures mucosa to 53.85% of the mucosal samples in the presence of cholesteatoma. hBD-3 gene expression was detected in most tissue samples with high microbial contamination: palatine tonsils (100%); adenoid hypertrophy (84.62%); adenoids in hypertrophic states of adenoids and palatine tonsils (87.5%); laryngeal fibrous-vascular polyps (87.5%); other laryngeal pathology (77.78% of the samples). The highest levels of hBD-3 gene expression were found in laryngeal fibrous-vascular polyps. The findings presumed two functionally different types of immune response in mucosa of the ORL organs. In the anatomical-functional areas lined with ciliated epithelium (middle and inferior nasal passages, maxillary and ethmoid sinuses, middle ear), significantly lower frequencies (Fisher's exact test, p < 0.05 to p < 0.001) and levels (Mann-Whitney test, p < 0.05 to p < 0.001) of hBD-3 gene expression were detected, except of polyps of the middle nasal passage and ethmoid labyrinth, and mucosa of the tympanic cavity in cholesteatoma, which may be related to the nature of the pathological process. In the areas lined with squamous epithelium or a combination of squamous and ciliated epithelium, hBD-3 gene expression was detected almost everywhere and at significantly higher levels. In the context of chronic inflammation and infection-related diseases of the ORL organs, in addition to the direct microbicidal activity of hBD-3 as the first line of immune response, one may suggest peptide dysregulation and, even, pathogenetic effects of hBD-3, e.g., increased sensitivity to infections, pathological changes in the composition of the commensal bacteria, fibrous remodeling.https://www.mimmun.ru/mimmun/article/view/2384human β-defensin-3gene expressionadenoidspalatine tonsilsnasal mucosasinonasal mucosanasal polypssinonasal polypschronic otitis mediaotosclerosislarynx
spellingShingle E. V. Tyrnova
G. M. Aleshina
Yu. K. Yanov
Human β-defensin-3gene expression in mucosa of ORL organs
Медицинская иммунология
human β-defensin-3
gene expression
adenoids
palatine tonsils
nasal mucosa
sinonasal mucosa
nasal polyps
sinonasal polyps
chronic otitis media
otosclerosis
larynx
title Human β-defensin-3gene expression in mucosa of ORL organs
title_full Human β-defensin-3gene expression in mucosa of ORL organs
title_fullStr Human β-defensin-3gene expression in mucosa of ORL organs
title_full_unstemmed Human β-defensin-3gene expression in mucosa of ORL organs
title_short Human β-defensin-3gene expression in mucosa of ORL organs
title_sort human β defensin 3gene expression in mucosa of orl organs
topic human β-defensin-3
gene expression
adenoids
palatine tonsils
nasal mucosa
sinonasal mucosa
nasal polyps
sinonasal polyps
chronic otitis media
otosclerosis
larynx
url https://www.mimmun.ru/mimmun/article/view/2384
work_keys_str_mv AT evtyrnova humanbdefensin3geneexpressioninmucosaoforlorgans
AT gmaleshina humanbdefensin3geneexpressioninmucosaoforlorgans
AT yukyanov humanbdefensin3geneexpressioninmucosaoforlorgans